Gender-related Differences in Pituitary Adenomas

 

 Buy Article Permissions and Reprints

Abstract

Pituitary adenomas account for about 10% of all intracranial neoplasms and for about 85% of all pituitary tumors. In addition, prospective studies of normal persons and postmortem examinations reveal pituitary adenomas in up to 10% of adults indicating that not all pituitary adenomas are clinically significant. With clinically significant pituitary adenomas, patients may present with hyper- or under-secretion of pituitary hormones or with symptoms and signs of space occupying intracranial tumor like headache and visual compromise. Like other differentiated neuroendocrine cells, the anterior pituitary displays remarkable plasticity in response to physiological demands, as exemplified by the lactotroph differentiation and proliferation of pregnancy or the thyrotroph hyperplasia of primary hypothyroidism. These reversible changes are mediated by a diverse array of signals that have been interpreted to support a role for hormonal stimulation in the pathogenesis of pituitary adenomas. Different investigators have shown a tendency to gender-related differences not only in surgical outcome, but also in the presenting symptoms and signs, duration of symptoms, tumor size, tumor histology, and restoration of normal pituitary function in patients who are surgically treated and histologically proven pituitary adenomas. In this review, we will try to give a systematic insight into gender related differences of pituitary adenomas. Special reference is given on potential different biology of these tumors as suggested by the gender related differences. The manuscript therefore gives new insights into the cellular understanding of the pituitary adenomas.

References

• 1 Apel R, Asa S. Update in aspects of endocrine pathology.  Pathology International. 2004;  54 ((Suppl. 1)) S118-S127
  CrossrefPubMedGoogle Scholar
• 2 Asa SL. Tumors of the Pituitary Gland Washington. DC: Armed Forces Institute of Pathology 1998
• 3 Buurman H, Saeger W. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.  Eur J Endocrinol. 2006;  154 753-758
  CrossrefPubMedGoogle Scholar
• 4 Carter JN, Tyson JE, Tolis G. et al . Prolactin-secreting tumors and hypogonadism in 22 men.  N Engl J Med. 1978;  299 847-852
  PubMedGoogle Scholar
• 5 Colao A, Di Sarno A, Cappabianca P. et al . Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia.  Eur J Endocrinol. 2003;  148 325-331
  CrossrefPubMedGoogle Scholar
• 6 Delgrange E, Trouillas J, Maiter D. et al . Sex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker Study.  J Clin Endocrinol Metab. 1999;  82 ((7)) 2102-2107
  PubMedGoogle Scholar
• 7 Ezzat S. Pituitary tumor pathogenesis – the hunt for novel candidate genes continues.  J Clin Endocrinol Metab. 2003;  88 5116-5118
  CrossrefPubMedGoogle Scholar
• 8 Finelli P, Larizza L. Pituitary Adenomas: Atlas of Genetics and Cytogenetics. 2005; 
  PubMed
• 9 Garber JR, Hedley-Whyte ET. A 44-year-old woman with headache, blurred vision, and an intrasellar mass.  N Engl J Med. 1995;  333 441-447
  CrossrefPubMedGoogle Scholar
• 10 Giraldi FP, Moro M, Cavagnini F. the study group on the hypothalamo-pituitary-adrenal axis of the italian society of endocrinology . Gender-Related Differences in the Presentation and Course of Cushing's Disease.  J Clin Endocrinol Metab. 2003;  88 ((4)) 1554-1558
  CrossrefPubMedGoogle Scholar
• 11 Gürlek A, Karavitaki N, Ansorge O. et al . What are the markers of aggressiveness in prolactinomas Changes in cell biology, extracellular matrix components, angiogenesis and genetics.  Eur J Endocrinol. 2007;  156 ((Issue 2)) 143-153
  CrossrefPubMedGoogle Scholar
• 12 Hall WA, Luciano MG, Doppman JL. et al . Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population.  Ann Intern Med. 1994;  120 817-820
  CrossrefPubMedGoogle Scholar
• 13 Koranyi J, Bosaeus I, Alpsten M. et al . Body composition during GH replacement in adults – methodological variations with respect to gender.  Eur J Endocrinol. 2006;  154 545-553
  CrossrefPubMedGoogle Scholar
• 14 Mindermann T, Wilson CB. Age-related and gender-related occurrence of pituitary adenomas.  Clin Endocrinol (Oxf). 1994 Sep;  41 ((3)) 359-364
  PubMedGoogle Scholar
• 15 Nishioka H, Haraoka J, Akada K. et al . Gender-related differences in prolactin secretion in pituitary prolactinomas.  Neuroradiology. 2002;  44 407-410
  CrossrefPubMedGoogle Scholar
• 16 Nishioka H, Haraoka J, Akada K. Growth potential of prolactinomas in men: is it really different from women?.  Surg Neurol. 2003;  59 386-390
  CrossrefPubMedGoogle Scholar
• 17 Pei L, Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG).  Mol Endocrinol. 1997;  11 433-441
  CrossrefPubMedGoogle Scholar
• 18 Saeger W, Ludecke DK, Buchfelder M. et al . Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.  Eur J Endocrinol. 2007;  156 203-216
  CrossrefPubMedGoogle Scholar
• 19 Schaller B, Kirsch E, Tolnay M. et al . Symptomatic granular cell tumor of the pituitary gland: case report and review of the literature.  Neurosurgery. 1998;  42 166-170
  CrossrefPubMedGoogle Scholar
• 20 Schaller B. Gender related differences in non-functioning pituitary adenomas.  Neuro Endocrinol Letters. 2003;  24 ((6)) 425-430
  PubMedGoogle Scholar
• 21 Schaller B. Gender-Related Differences in Growth Hormone-Releasing Pituitary Adenomas. A Clinicopathological Study.  Pituitary. 2002;  5 247-253
  CrossrefPubMedGoogle Scholar
• 22 Schaller B. Gender-related differences in prolactionomas. A clinicopathological study.  Neuroendcrinol Lett. 2005;  26 ((2)) 152-159
  PubMedGoogle Scholar
• 23 Scheithauer BW, Gaffey TA, Lloyd RV. et al . Pathobiology of pituitary adenomas and carcinomas.  Neurosurgery. 2006;  59 341-353
  CrossrefPubMedGoogle Scholar
• 24 Schlechte J, Sherman B, Halmi N. et al . Prolactin-secreting pituitary tumors in amenorrheic women: a comprehensive study.  Endocr Rev. 1980;  1 295-308
  CrossrefPubMedGoogle Scholar
• 25 Schlechte JA. Prolactinoma.  N Engl J Med. 2003;  349 2035-2041
  CrossrefPubMedGoogle Scholar
• 26 Seizaburo S, Hitoshi T, Takeo F. et al . Biology of pituitary adenoma: an endocrinological, immunohistochemical and argyrophil nucleolar organizer region (Ag-NOR) studies with special reference to invasive adenoma.  Medical Bulletin of Fukuoka University. 2001;  28 77-88
  PubMedGoogle Scholar
• 27 Spada A, Lania A, Mantovani G. hormonal signaling and pituitary adenomas.  Neuroendocrinology. 2007;  85 101-109
  CrossrefPubMedGoogle Scholar
• 28 Sylvia LA, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas.  Endocrine Reviews. 1998;  19 ((6)) 798-827
  CrossrefPubMedGoogle Scholar
• 29 Tfelt-Hansen J, Kanuparthi D, Chattopadhyay N. The emerging role of pituitary tumors transforming gene in tumorigenesis.  Clin Med Res. 2006;  4 130-137
  CrossrefPubMedGoogle Scholar
• 30 Zou H, McGarry TJ, Bernal T. et al . Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis.  Science. 1999;  285 418-422
  CrossrefPubMedGoogle Scholar

Correspondence

B. D. ArashoMD 

Department of Neurology

Faculty of Medicine

Addis Ababa University

Ethiopia

Email: belachewda@yahoo.com